These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 16430665)

  • 1. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light.
    Cardo LJ; Rentas FJ; Ketchum L; Salata J; Harman R; Melvin W; Weina PJ; Mendez J; Reddy H; Goodrich R
    Vox Sang; 2006 Feb; 90(2):85-91. PubMed ID: 16430665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light.
    Cardo LJ; Salata J; Mendez J; Reddy H; Goodrich R
    Transfus Apher Sci; 2007 Oct; 37(2):131-7. PubMed ID: 17950672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasma.
    Tonnetti L; Proctor MC; Reddy HL; Goodrich RP; Leiby DA
    Transfusion; 2010 May; 50(5):1019-27. PubMed ID: 20030791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
    Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
    Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates.
    Ambruso DR; Thurman G; Marschner S; Goodrich RP
    Transfusion; 2009 Dec; 49(12):2631-6. PubMed ID: 19694996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet light.
    Keil SD; Kiser P; Sullivan JJ; Kong AS; Reddy HL; Avery A; Goodrich RP
    Transfusion; 2013 Oct; 53(10):2278-86. PubMed ID: 23320495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.
    Li J; de Korte D; Woolum MD; Ruane PH; Keil SD; Lockerbie O; McLean R; Goodrich RP
    Vox Sang; 2004 Aug; 87(2):82-90. PubMed ID: 15355498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma.
    Smith J; Rock G
    Transfusion; 2010 Apr; 50(4):926-31. PubMed ID: 20051060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C.
    Bihm DJ; Ettinger A; Buytaert-Hoefen KA; Hendrix BK; Maldonado-Codina G; Rock G; Giclas PC; Goodrich RP
    Vox Sang; 2010 Feb; 98(2):108-15. PubMed ID: 19719460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light.
    Ruane PH; Edrich R; Gampp D; Keil SD; Leonard RL; Goodrich RP
    Transfusion; 2004 Jun; 44(6):877-85. PubMed ID: 15157255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania inactivation in human pheresis platelets by a psoralen (amotosalen HCl) and long-wavelength ultraviolet irradiation.
    Eastman RT; Barrett LK; Dupuis K; Buckner FS; Van Voorhis WC
    Transfusion; 2005 Sep; 45(9):1459-63. PubMed ID: 16131378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogen-reduction systems for blood components: the current position and future trends.
    Seghatchian J; de Sousa G
    Transfus Apher Sci; 2006 Dec; 35(3):189-96. PubMed ID: 17110168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: Results of a three-arm in vitro study.
    Picker SM; Steisel A; Gathof BS
    Transfus Apher Sci; 2009 Apr; 40(2):79-85. PubMed ID: 19233725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units.
    Picker SM; Steisel A; Gathof BS
    Transfusion; 2008 Aug; 48(8):1685-92. PubMed ID: 18513255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins.
    Hornsey VS; Drummond O; Morrison A; McMillan L; MacGregor IR; Prowse CV
    Transfusion; 2009 Oct; 49(10):2167-72. PubMed ID: 19555414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants.
    Asano H; Lee CY; Fox-Talbot K; Koh CM; Erdinc MM; Marschner S; Keil S; Goodrich RP; Baldwin WM
    Transplantation; 2007 Nov; 84(9):1174-82. PubMed ID: 17998874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.
    Keil SD; Saakadze N; Bowen R; Newman JL; Karatela S; Gordy P; Marschner S; Roback J; Hillyer CD
    Transfusion; 2015 Apr; 55(4):858-63. PubMed ID: 25438832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoinactivation of Leishmania donovani infantum in red cell suspensions by a flexible thiopyrylium sensitizer.
    Wagner SJ; Skripchenko A; Salata J; Cardo LJ
    Vox Sang; 2006 Aug; 91(2):178-80. PubMed ID: 16907880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riboflavin and UV light treatment of platelets: a protective effect of platelet additive solution?
    van der Meer PF; Bontekoe IJ; Daal BB; de Korte D
    Transfusion; 2015 Aug; 55(8):1900-8. PubMed ID: 25752624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction.
    AuBuchon JP; Herschel L; Roger J; Taylor H; Whitley P; Li J; Edrich R; Goodrich RP
    Transfusion; 2005 Aug; 45(8):1335-41. PubMed ID: 16078923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.